Kidney Transplantation Clinical Trial
Official title:
PREventive Effect of FENestration With and Without Clipping on Post-Kidney Transplantation Lymphatic Complications: PREFEN Trial
Post-Kidney Transplantation Lymphatic complications include lymphorrhea and lymphocele, and are some of the most challenging issues after kidney transplantation. The most frequent post-Kidney transplantation complication is accumulation of perirenal fluids, such as urinomas, hematomas, and lymphoceles. Lymphoceles are associated with morbidities such as abdominal discomfort, impaired wound healing, and thrombosis. Lymphoceles may also affect graft function by putting direct pressure on the kidney, or by compressing the ureter or transplant vasculature. The frequency and consequences of post-transplantation lymphoceles make preventive measures highly desirable. Peritoneal fenestration during kidney Transplantation is a simple method for preventing lymphocele formation. Recent studies have evaluated the effectiveness of clipping with metallic clips following fenestration on lymphocele formation and lymph leakage after prostate cancer surgery and laparoscopic retroperitoneal lymph node dissection. However, whether clipping prevents lymphocele formation after kidney transplantation has not been investigated. The aim of the proposed study is to compare the effect of fenestration with and without clipping on incidence of post-kidney transplantation lymphocele and lymphorrhea.
Recent improvements in transplantation techniques, organ matching systems, and modern
immunosuppressive regiments have made kidney transplantation a routine operation with
acceptable mortality and morbidity rates. Post-kidney transplantation morbidities include
vascular and urological complications, and postoperative fluid collections. Perirenal fluid
collections, such as urinomas, hematomas, and lymphoceles, are some of most frequent
complications following Kidney transplantation, among which post-Kidney transplantation
lymphatic collections, are most challenging complications.
The incidence of post-kidney transplantation lymphatic complications is up to 50% and the
peak incidence of lymphocele is during the 6th postoperative week (range: 2 weeks to 6
months).
Lymphoceles are usually asymptomatic and identified incidentally by routine ultrasound
examination. However lymphoceles may result in morbidities such as abdominal discomfort,
impaired wound healing, and thrombosis. Post-kidney transplantation lymphatic complications
may also affect graft function by putting pressure on the kidney, or by compressing the
ureter or transplant vasculature. The frequency and consequences of post-transplantation
lymphoceles make preventive measures highly desirable.
Various preventive methods have been proposed in the literature. Lymphoceles usually
originate from unligated lymphatic vessels, therefore precise ligation of donor and recipient
lymphatic vessels can reduce lymphocele formation. Compression therapy of the lower limb
after kidney transplantation and appropriate immunosuppressive therapy may also reduce
lymphocele formation. Some authors have used polymeric sealants/hemostatic biomaterials or
povidone-iodine to prevent lymphocele formation. However, the effectiveness and
cost-efficiency of these methods has not been conclusively proven. Use of drains in
lymphocele prevention has also been previously suggested, but this method remains
controversial. Peritoneal fenestration at the time of kidney transplantation is a simple
method to prevent lymphocele formation. This method has been widely studied in treatment and
prevention of lymphoceles following kidney transplantation. However, to the best of our
knowledge, only one randomized controlled trial has been performed to investigate the impact
of preventive fenestration in prevention of post kidney transplantation lymphatic
complications. This study showed that the prevalence of fluid collections in the fifth
postoperative week was significantly higher in the standard group compared to fenestration
group. Also, 15.5% of patients in the standard group developed symptomatic lymphoceles
requiring treatment during the first postoperative year, versus 3.0% in the fenestration
group.
Recent studies have evaluated the effectiveness of extensive clipping using metallic clips
following fenestration on lymphocele formation and lymph leakage after prostate cancer
surgery and laparoscopic retroperitoneal lymph node dissection. Some surgeons have declared
concerns that larger fenestrations increase the risk of hernia. However, risk of closure of
the peritoneal fenestration is higher for smaller Windows in the peritoneal cavity. Recently
clipping of the edges of peritoneal fenestration was performed in the surgical clinic of the
Heidelberg University Hospital to reduce risk of closure of the fenestration after kidney
transplantation. However, whether fenestration and clipping prevents lymphocele formation
after kidney transplantation has not been investigated.
This clinical Trial is designed to investige the rate of post-kidney transplantation
lymphocele and lymphorrhea in two groups of kidney transplantation patients: one with only
fenestration and one with fenestration and clipping of the edges. Additionally, graft
function and incidence rate of other morbidities will be investigated and analyzed after
transplantation.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04910867 -
APOL1 Genetic Testing Program for Living Donors
|
N/A | |
Completed |
NCT02723591 -
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
|
Phase 4 | |
Completed |
NCT05945511 -
Silent Gallbladder Stone in Kidney Transplantation Recipients: Should it be Treated?
|
||
Completed |
NCT02234349 -
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Not yet recruiting |
NCT05934383 -
Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension
|
N/A | |
Withdrawn |
NCT04936971 -
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
|
Phase 4 | |
Not yet recruiting |
NCT04540640 -
Oxygenated Machine Preservation in Kidney Transplantation
|
N/A | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Recruiting |
NCT02908139 -
Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant Recipients
|
N/A | |
Terminated |
NCT02417870 -
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02560558 -
Bela 8 Week Dosing
|
Phase 4 | |
Recruiting |
NCT02154815 -
Pre-emptive Kidney Transplantation Quality of Life
|
N/A | |
Completed |
NCT02235571 -
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
|
N/A | |
Enrolling by invitation |
NCT01905514 -
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
|
N/A | |
Completed |
NCT02147210 -
Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1
|
N/A | |
Recruiting |
NCT01699360 -
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
|
Phase 4 | |
Terminated |
NCT01436305 -
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
|
Phase 2 | |
Completed |
NCT01655563 -
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
|
Phase 2 |